Agenus Investor Relations Material
Latest events
Q1 2025
Agenus
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Agenus Inc
Access all reports
Agenus Inc. is a biotechnology company focused on the discovery and development of immunotherapies for cancer and other diseases. The company specializes in antibody-based therapies, including immune checkpoint inhibitors and personalized cancer vaccines. Agenus leverages its proprietary research platforms to develop novel treatments that enhance the body's immune response against tumors. Agenus Inc. is headquartered in Lexington, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
AGEN
Country
🇺🇸 United States